Abstract:Approximately 1.7 million new cases of cancer will be diagnosed this year in the United States leading to 600 000 deaths. Patient survival rates are highly correlated with the stage of cancer diagnosis, with localized and regional remission rates that are much higher than for metastatic cancer. The current standard of care for many solid tumors includes imaging and biopsy with histological assessment. In many cases, after tomographical imaging modalities have identified abnormal morphology consistent with cancer, surgery is performed to remove the primary tumor and evaluate the surrounding lymph nodes. Accurate identification of tumor margins and staging are critical for selecting optimal treatments to minimize recurrence. Visible, fluorescent, and radiolabeled small molecules have been used as contrast agents to improve detection during real-time intraoperative imaging. Unfortunately, current dyes lack the tissue specificity, stability, and signal penetration needed for optimal performance. Quantum dots (QDs) represent an exciting class of fluorescent probes for optical imaging with tunable optical properties, high stability, and the ability to target tumors or lymph nodes based on surface functionalization. Here, state-of-the-art biocompatible QDs are compared with current Food and Drug Administration approved fluorophores used in cancer imaging and a perspective on the pathway to clinical translation is provided.

Optical Imaging-Guided Cancer Diagnosis and Therapy with Quantum Dots

Quantum Dots in Cancer Research

Quantum Dots For Cancer Therapy And Bioimaging

A Novel Molecular Imaging Probe:Application of Quantum Dots in Cancer Imaging & Early Diagnosis

Quantum Dots as a Potential Multifunctional Material for the Enhancement of Clinical Diagnosis Strategies and Cancer Treatments

Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents

Recent Progress in the Development of Carbon Quantum Dots for Cell Imaging

In vivo cancer targeting and imaging with semiconductor quantum dots

Bioconjugated Quantum Dots for in Vivo Molecular and Cellular Imaging☆

Quantum dot-based nanoprobes for in vivo targeted imaging.

Recent Breakthroughs in Using Quantum Dots for Cancer Imaging and Drug Delivery Purposes

Research Advances of Techniques for Quantum Dots-based Tumor Marker Detection

Molecular Profiling of Single Cancer Cells and Clinical Tissue Specimens with Semiconductor Quantum Dots.

Recent advances of carbon dots in imaging-guided theranostics

Micro-/nano-fluidic devices and in vivo fluorescence imaging based on quantum dots for cytologic diagnosis

Bright Semiconductor Quantum Dots Shed New Light on Precision Nanomedicine for Various Diseases

In Vivo Cancer Targeting and Imaging-Guided Surgery with Near Infrared-Emitting Quantum Dot Bioconjugates

[Application and Development of Quantum Dots in the Imaging of Lymph Node Metastasis].

Carbon quantum dots: Preparation, optical properties, and biomedical applications

Application of quantum dots in biological imaging

Biological Applications of Carbon Quantum Dots: Bioimaging, Drug Delivery and Toxicity